Lazard is acting as the exclusive financial advisor to Collegium. Hogan Lovells is serving as M&A legal counsel to Collegium. Goodwin Procter LLP is serving as...
Collegium Pharmaceutical’s $525 Million Acquisition Of Ironshore Therapeutics
Acino’s Acquisition of M8 Pharmaceuticals
Banco J.P. Morgan S.A. is acting as exclusive financial advisor, Goodwin LLP as exclusive legal advisor, and PWC as exclusive accounting and tax advisor to Acino....
Seagen and Nurix’s Strategic Collaboration
Goodwin advised Seagen on the deal. Nurix Therapeutics, Inc. (Nasdaq: NRIX) announced that it has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc....
Rapport Therapeutics’ $150 Million Series B Funding Round
Goodwin advised Rapport Therapeutics on the fundraising. Rapport Therapeutics announced the completion of its $150 million in Series B funding. Led by Cormorant Asset Management, the...
Teledyne’s Acquisition of ETM-Electromatic
Goodwin advised ETM-Electromatic, Inc. on the deal. ETM-Electromatic, Inc. announced its acquisition by a wholly-owned subsidiary of Teledyne Technologies Incorporated (NYSE:TDY). ETM, headquartered in Newark, California, designs...
OPKO Health’s Acquisition of ModeX Therapeutics
Goodwin advised ModeX Therapeutics, Inc. on the deal while Greenberg Traurig represented OPKO Health Inc. ModeX Therapeutics, Inc. announced its sale to OPKO Health, Inc. (NASDAQ: OPK)...
Viatris’ $3.335 Billion Combination of Biosimilars Portfolio with Biocon Biologics
Cravath and Saraf and Partners represented Viatris in the transaction while Shardul Amarchand Mangaldas & Co and Goodwin Procter advised Biocon Biologics. Viatris Inc. reached a...